Twitter Facebook YouTube Google+ LinkedIn RSS Feed

Supplemental Reports Available for Select Tests [Updated]

Starting this week, a select number of Mayo Medical Laboratories test results will include a supplemental report, providing more details and/or improved format than what is currently possible with our laboratory information system. This new functionality, to be available for 13 tests initially, will enable you to view an additional report, which may include more information, charts, images and other enriched information.

How will you know there is a supplemental report?

There are four ways to access supplemental reports:

An example of the supplemental information included in our new supplemental reports. The example above is from our test: BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML).

An example of the supplemental information included in our new supplemental reports.

  • Subscribe to MayoAccess email notifications by contacting Client Support or your Regional Service Representative.
  • Search for results in the “lab reports” view in MayoAccess. Tests with supplemental reports will be flagged with an “RI” symbol, which will be displayed in the search result grid.
  • Print your test reports in MayoAccess and any supplemental report will be included in the print out.
  • Use the hyperlink included in the test result returned to your laboratory information system or MayoAccess.

 

How will supplemental reports be transmitted to interfaces?

The message and hyperlink to the report will be sent your interface in an NTE field.  Copy and paste the link into Internet Explorer to retrieve that specific report or log into MayoAccess and search for that patient report.

 

List of tests with supplemental reports

Effective Test Test Name Types File
10/28/13 JAK2V
31156
JAK2 V617F Mutation Detection, Varies Test Changes
10/28/13 BAKDM
89609
BCR/ABL, Tyrosine Kinase Inhibitor Resistance, Kinase Domain Mutation Screen Test Changes
10/28/13 BCRAB
89007
BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML) Test Changes
10/28/13 PBLI
9302
Plasma Cell Assessment, Blood Test Changes
10/28/13 TAE
82977
Therapeutic Antibody by Flow Cytometry Test Changes
10/28/13 PCPRO
61654
Plasma Cell DNA Content and Proliferation, Bone Marrow Test Changes
10/28/13 JAK2M
31155
JAK2 V617F Mutation Detection, Bone Marrow Test Changes
10/28/13 JAK2B
88715
JAK2 V617F Mutation Detection, Blood Test Changes
10/28/13 LCMS
3287
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry Test Changes
10/28/13 HLLFH
34854
Hematologic Disorders, Leukemia/Lymphoma; Flow Hold Varies Test Changes
10/28/13 CLLM
60490
CLL Monitoring, MRD Detection, Blood Test Changes
10/28/13 PLINK
62139
PNH, PI-Linked Antigen, Blood Test Changes
10/28/13 PCLLM
20437
CLL Monitoring, MRD Detection FLIP, see #60490 Test Changes
10/28/13 ZAP70
83727
ZAP-70, Chronic Lymphocytic Leukemia (CLL) Prognosis Test Changes
10/28/13 LLPT
19499
Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue Test Changes
This entry was posted in Testing.

5 Responses to this post